Reaction
Pleural Neoplasm reporting signals
As of the last recalculation, Pleural Neoplasm appears in 163 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is ADO-TRASTUZUMAB EMTANSINE (PRR 178.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ado-Trastuzumab Emtansine | 11 | 178.6 | 178.8 |
| Exemestane | 24 | 167.6 | 167.8 |
| Fulvestrant | 29 | 136.1 | 136.3 |
| Goserelin | 13 | 134.3 | 134.4 |
| Everolimus Tablets | 15 | 125.7 | 125.8 |
| Anastrozole Tablets | 16 | 105.5 | 105.6 |
| Letrozole Tablets | 30 | 97.4 | 97.4 |